Michael Wong

973 total citations
22 papers, 549 citations indexed

About

Michael Wong is a scholar working on Molecular Biology, Epidemiology and Oncology. According to data from OpenAlex, Michael Wong has authored 22 papers receiving a total of 549 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Epidemiology and 4 papers in Oncology. Recurrent topics in Michael Wong's work include Phytochemistry and Bioactive Compounds (2 papers), interferon and immune responses (2 papers) and Metabolomics and Mass Spectrometry Studies (2 papers). Michael Wong is often cited by papers focused on Phytochemistry and Bioactive Compounds (2 papers), interferon and immune responses (2 papers) and Metabolomics and Mass Spectrometry Studies (2 papers). Michael Wong collaborates with scholars based in United States, Canada and Hong Kong. Michael Wong's co-authors include David E. Greenberg, Seth M. Daly, Thomas Money, Haitao Xiao, Chengyuan Lin, Siu Wai Tsang, Zhaoxiang Bian, Patrick L. Iversen, Jay Saoud and Jay S. Charleston and has published in prestigious journals such as New England Journal of Medicine, PLoS ONE and Chemical Communications.

In The Last Decade

Michael Wong

22 papers receiving 531 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Wong United States 13 226 82 77 73 65 22 549
Sravan Kumar Miryala India 14 348 1.5× 91 1.1× 95 1.2× 56 0.8× 47 0.7× 18 537
Jufeng Xia Japan 17 273 1.2× 76 0.9× 54 0.7× 30 0.4× 110 1.7× 26 737
Geetha B. Kumar India 14 272 1.2× 37 0.5× 44 0.6× 62 0.8× 34 0.5× 40 557
Kenji Namba Japan 10 161 0.7× 112 1.4× 136 1.8× 26 0.4× 105 1.6× 18 446
Ayako Hara Japan 13 271 1.2× 72 0.9× 75 1.0× 38 0.5× 46 0.7× 28 605
Hua Yu China 17 498 2.2× 27 0.3× 93 1.2× 57 0.8× 60 0.9× 29 727
Yashwant Kumar India 14 310 1.4× 84 1.0× 32 0.4× 25 0.3× 87 1.3× 55 697
Larance Ronsard United States 17 301 1.3× 130 1.6× 47 0.6× 41 0.6× 156 2.4× 37 687
Krishna Sarva United States 12 389 1.7× 155 1.9× 214 2.8× 148 2.0× 150 2.3× 22 669
Yinhui Dong China 17 325 1.4× 82 1.0× 68 0.9× 55 0.8× 86 1.3× 25 666

Countries citing papers authored by Michael Wong

Since Specialization
Citations

This map shows the geographic impact of Michael Wong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Wong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Wong more than expected).

Fields of papers citing papers by Michael Wong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Wong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Wong. The network helps show where Michael Wong may publish in the future.

Co-authorship network of co-authors of Michael Wong

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Wong. A scholar is included among the top collaborators of Michael Wong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Wong. Michael Wong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Beigel, John H., Jocelyn Voell, Paula Muñoz, et al.. (2017). Safety, tolerability, and pharmacokinetics of radavirsen (AVI‐7100), an antisense oligonucleotide targeting influenza a M1/M2 translation. British Journal of Clinical Pharmacology. 84(1). 25–34. 19 indexed citations
3.
Ayhan, Dilay Hazal, Yusuf Talha Tamer, Mohammed Akbar, et al.. (2016). Sequence-Specific Targeting of Bacterial Resistance Genes Increases Antibiotic Efficacy. PLoS Biology. 14(9). e1002552–e1002552. 66 indexed citations
4.
Sully, Erin K., Bruce L. Geller, Lixin Li, et al.. (2016). Peptide-conjugated phosphorodiamidate morpholino oligomer (PPMO) restores carbapenem susceptibility to NDM-1-positive pathogensin vitroandin vivo. Journal of Antimicrobial Chemotherapy. 72(3). dkw476–dkw476. 36 indexed citations
5.
Heald, Alison E., Jay S. Charleston, Patrick L. Iversen, et al.. (2015). AVI-7288 for Marburg Virus in Nonhuman Primates and Humans. New England Journal of Medicine. 373(4). 339–348. 40 indexed citations
6.
Nair, Anilkumar G., Michael Wong, Youheng Shu, et al.. (2014). IV. Discovery of CXCR3 antagonists substituted with heterocycles as amide surrogates: Improved PK, hERG and metabolic profiles. Bioorganic & Medicinal Chemistry Letters. 24(4). 1085–1088. 12 indexed citations
7.
Heald, Alison E., Patrick L. Iversen, Jay Saoud, et al.. (2014). Safety and Pharmacokinetic Profiles of Phosphorodiamidate Morpholino Oligomers with Activity against Ebola Virus and Marburg Virus: Results of Two Single-Ascending-Dose Studies. Antimicrobial Agents and Chemotherapy. 58(11). 6639–6647. 57 indexed citations
8.
9.
Xiao, Haitao, Chengyuan Lin, Jiao Peng, et al.. (2013). Inhibitory Effect of the Gallotannin Corilagin on Dextran Sulfate Sodium-Induced Murine Ulcerative Colitis. Journal of Natural Products. 76(11). 2120–2125. 78 indexed citations
10.
Yu, Hui, Michael Wong, Shuai Zhao, et al.. (2012). A simple and robust LC‐MS/MS method for quantification of free 3‐nitrotyrosine in human plasma from patients receiving on‐pump CABG surgery. Electrophoresis. 33(4). 697–704. 16 indexed citations
12.
Xu, Min, Bin Deng, Kelvin Sze‐Yin Leung, et al.. (2010). The effects of Boehmeria nivea (L.) Gaud. on embryonic development: In vivo and in vitro studies. Journal of Ethnopharmacology. 134(2). 393–398. 18 indexed citations
13.
Anilkumar, G., James W. Hall, Doug W. Hobbs, et al.. (2010). II. SAR studies of pyridyl–piperazinyl-piperidine derivatives as CXCR3 chemokine antagonists. Bioorganic & Medicinal Chemistry Letters. 21(5). 1527–1531. 16 indexed citations
14.
Lavey, Brian J., Joseph A. Kozlowski, Bandarpalle B. Shankar, et al.. (2007). Optimization of triaryl bis-sulfones as cannabinoid-2 receptor ligands. Bioorganic & Medicinal Chemistry Letters. 17(13). 3760–3764. 13 indexed citations
15.
Knight, R., Samuel L. Stanley, Michael Wong, & Gerard Dolan. (2006). Hemophilia Therapy and Blood-Borne Pathogen Risk. Seminars in Thrombosis and Hemostasis. 32(S 2). 3–9. 12 indexed citations
16.
Money, Thomas, et al.. (1996). An enantiospecific synthetic approach to the limonoids. Chemical Communications. 667–667. 9 indexed citations
17.
Ferguson, Colin G., et al.. (1996). A remarkable multiple rearrangement process in the bromination of endo-3-bromo-4-methylcamphor: Intermediates for triterpenoid synthesis. Tetrahedron. 52(47). 14661–14672. 4 indexed citations
18.
Money, Thomas & Michael Wong. (1996). A formal, enantiospecific synthesis of pseudoguaianolides. Tetrahedron. 52(18). 6307–6324. 21 indexed citations
19.
Wong, Michael, J. M. Hill, & Marc P. Kaufman. (1995). Pressor responses to stimulation of non-NMDA receptors in the superficial laminae of the cat spinal cord. Brain Research. 683(1). 149–152. 4 indexed citations
20.
Wong, Michael, Bronwyn Scott, & Charles M. Peterson. (1992). Breath acetaldehyde following ethanol consumption. Alcohol. 9(3). 189–192. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026